VisualDx

VisualDx is a web-based clinical decision support system that assists healthcare professionals in making accurate diagnoses and treatment decisions. It offers an extensive medical image library, smart search functions, and diagnosis builders, enabling clinicians to efficiently construct differential diagnoses and explore various conditions. The platform's primary objective is to improve healthcare decision-making and reduce diagnostic errors.

A key feature of VisualDx is its ability to guide users through the process of building a differential diagnosis based on patient symptoms, dermatological presentations, and drug reactions. The system prompts clinicians to consider additional relevant questions, helping to mitigate the impact of factors such as cognitive fatigue and distractions.

In addition to its diagnostic capabilities, VisualDx provides concise, actionable synopses for a wide range of conditions spanning multiple specialties, including dermatology, infectious diseases, psychiatry, and more. These synopses cover essential information such as differential diagnoses, workups, treatments, and clinical pearls, making them a valuable resource for clinicians at the point of care.

Furthermore, VisualDx offers over 400 patient handouts, facilitating effective communication and education for patients. The platform is seamlessly integrated with UpToDate and electronic health record (EHR) systems, enhancing its utility and workflow integration.

To support continuing medical education (CME), VisualDx allows clinicians to earn AMA PRA Category one CME credits for their searches and diagnostic activities within the platform. This feature incentivizes ongoing learning and professional development while streamlining the CME process.

In recent years, VisualDx has expanded its reach through various partnerships and initiatives. For instance, it has collaborated with organizations like Vaseline to enhance provider education on skin of color, and with the American Medical Women's Association (AMWA) to offer assistive technology to its members. Additionally, the company has received grants and worked with government agencies to develop diagnostic tools for public health threats and infectious diseases.